Randomized trial of daily versus three-times-weekly prophylactic ganciclovir after lung and heart-lung transplantation

Journal of Heart and Lung Transplantation

Volumn 17, Issue 9, 1998, Pages 913-920

  Hertz, M I ^a   Jordan, C ^a   Savik, S K ^a   Fox, J M K ^a   Park, S ^a   Bolman II, R M ^a   Dosland Mullan, B M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; GANCICLOVIR; METHYLPREDNISOLONE;

ADULT; ARTICLE; BRONCHIOLITIS; CATHETER INFECTION; CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DOSE RESPONSE; FEMALE; HEART LUNG TRANSPLANTATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SURVIVAL;

ANTIVIRAL AGENTS; BRONCHIOLITIS OBLITERANS; CYTOMEGALOVIRUS INFECTIONS; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; GANCICLOVIR; HEART-LUNG TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 0031663240     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)